why choose us

First received: July 5, 2022

Clinical Trial: Plasma MicroRNA for Prediction of Hepatocellular Carcinoma

Study Status: Completed

Recruit Status: Completed

Condition: Hepatitis C

Study Type: Observational


Official Title: Plasma Expression Levels of MicroRNA-21 Might Help for Detection of HCV Patients Complicated by Hepatocellular Carcinoma

Brief Summary: 100 patients with diagnosed HCV were evaluated by clinical and ultrasound examination and were categorized as uncomplicated HCV (n=22) and complicated HCV (n=78). All patients were evaluated for hepatosteatosis and liver fibrosis using the computerized hepatorenal index, the hepatic steatosis index, aspartate aminotransferase (AST)/platelet count index (APRI) and the Fibrosis-4 (FIB-4) scores. Blood samples were obtained for estimation of serum levels of liver function tests and plasma levels of microRNA 21 and…

Read more